Congress NYC to Fund Coronavirus Surveillance Sequencing as Congress Proposes $2B for Nationwide Program Companion bills to be introduced in the House and Senate on Thursday would task the CDC with identifying and tracking emerging SARS-CoV-2 variants. President Trump Signs FY 2021 Spending Bill to Boost NIH Budget 3 Percent The bill, which Congress overwhelmingly approved last week, also includes additional funding for the US Centers for Disease Control and Prevention. Congress Approves 3 Percent Increase in NIH Budget for Fiscal 2021 The bill, which was overwhelming passed by both the Senate and the House, would boost the National Institutes of Health's budget by $1.25 billion. Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs Premium The move raises questions about what precisely is an LDT outside of FDA jurisdiction and heightens concerns that poorly validated tests will enter the market and endanger public health. House Committee Votes for $5.5B Boost to NIH Budget The appropriations committee recommended that the NIH receive a total of $46.96 billion in NIH funding for FY 2021, a nearly 13 percent increase over its current budget. Apr 10, 2020 Congressional Leaders Seek Coronavirus Test Information From FDA Mar 27, 2020 NIH, CDC to Receive Billions in Additional Funding Under Coronavirus Stimulus Bill Dec 17, 2019 House Subcommittee Bill Proposes 7 Percent NIH Budget Increase Sep 18, 2019 Senate Subcommittee Seeks $3B Boost to NIH Budget Jun 20, 2019 With US Congress Considering Changes to Patent Laws, Dx Stakeholders Offer Differing Views Premium Jun 17, 2019 Genetic Counseling Medicare Payment Bill Introduced in Congress Jun 11, 2019 Senators Probe CMS Payments to US Providers Who Partnered With China-Linked Genomics Firms Jun 4, 2019 US Senate Hearings Consider Bipartisan Proposal to Change Patent Laws; Could Have Big Impact on Dx May 1, 2019 House Subcommittee Approves $2B Boost to NIH Funding Mar 11, 2019 White House Proposes 12 Percent Cut to NIH Budget in Fiscal 2020 Dec 10, 2018 Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation Nov 15, 2018 FDA, Industry Willing to Collaborate on Dx Regulation via Legislation Despite Differences Premium Oct 29, 2018 Genetic Counselors Push to Advance Legislation to Allow Medicare Billing Premium Oct 24, 2018 Genetic Counseling Medicare Bill Introduced in Congress Sep 27, 2018 House of Representatives Approves NIH Funding Increase Sep 17, 2018 Congressional Committee Approves $2B Increase in NIH Funding Aug 24, 2018 US Senate Passes FY 2019 Appropriations Bill With NIH Funding Increase Aug 8, 2018 FDA Details Vision for Regulating In Vitro Clinical Tests to Legislators Jun 26, 2018 Senate Subcommittee Proposes 5.4 Percent Boost to 2019 NIH Budget Jun 15, 2018 House Committee Proposes 3 Percent Boost to NIH Funding Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.